SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-040708
Filing Date
2019-11-06
Accepted
2019-11-06 09:08:11
Documents
75
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q cnst-10q_20190930.htm 10-Q 2851305
2 EX-31.1 cnst-ex311_9.htm EX-31.1 9612
3 EX-31.2 cnst-ex312_7.htm EX-31.2 9585
4 EX-32.1 cnst-ex321_6.htm EX-32.1 5684
5 EX-32.2 cnst-ex322_10.htm EX-32.2 5766
  Complete submission text file 0001564590-19-040708.txt   7834249

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cnst-20190930.xml EX-101.INS 1452222
7 XBRL TAXONOMY EXTENSION SCHEMA cnst-20190930.xsd EX-101.SCH 54147
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnst-20190930_cal.xml EX-101.CAL 51475
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnst-20190930_def.xml EX-101.DEF 184992
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnst-20190930_lab.xml EX-101.LAB 409218
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnst-20190930_pre.xml EX-101.PRE 320260
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Filer) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38584 | Film No.: 191195256
SIC: 2834 Pharmaceutical Preparations